Florian Poullenot
YOU?
Author Swipe
View article: Adherence to home parenteral nutrition and/or intravenous fluid infusions in patients with chronic intestinal failure: A multicenter cross-sectional study
Adherence to home parenteral nutrition and/or intravenous fluid infusions in patients with chronic intestinal failure: A multicenter cross-sectional study Open
One in four CIF patients showed poor adherence. Those with low infusion volumes, high anxiety, or low physician trust require close monitoring. Coordinating nurses play a key role in identifying non-adherence.
View article: Intestinal failure–associated liver disease in adult patients with chronic intestinal failure receiving home parenteral nutrition: A descriptive cohort study
Intestinal failure–associated liver disease in adult patients with chronic intestinal failure receiving home parenteral nutrition: A descriptive cohort study Open
Background Intestinal failure–associated liver disease (IFALD) is a major complication of chronic intestinal failure. Few data exist about hepatic monitoring of IFALD using the liver stiffness measurement. The aim of this study was to prov…
View article: Safety of Advanced Combination Treatment With Selective <scp>JAK1</scp> Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience
Safety of Advanced Combination Treatment With Selective <span>JAK1</span> Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience Open
This multicenter retrospective study examines 18 patients with difficult‐to‐treat inflammatory bowel diseases who received advanced combination treatment (ACT) with selective JAK1 inhibitors and biologics, totaling 11.8 patient‐years of ex…
View article: Healthcare workers’ opinions on non-medical criteria for prioritisation of access to care during the pandemic
Healthcare workers’ opinions on non-medical criteria for prioritisation of access to care during the pandemic Open
Prioritisation recommendations in case of scarce medical resources were not necessarily approved by the frontline physicians, or by the other HCWs. This questions the way ethical recommendations should be communicated and discussed at a lo…
View article: Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study
Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study Open
We did not find a statistically significant increase in incident breast cancer related to IBD treatment beyond the already known poor prognostic factors of breast cancer.
View article: Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis
Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis Open
Immune checkpoint inhibitors (ICIs) present clinicians with the challenge of managing immune-related adverse events (irAEs), which can range from mild to severe due to immune system activation 1 . While guidelines recommend discontinuing I…
View article: P679 Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial
P679 Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial Open
Background Achieving deep and continuous remission with tight control could allow de-escalation in patients with UC. The in-TARGET study was a prospective two-phase trial in UC patients initiating golimumab (GLM), that aimed to determine t…
View article: P173 Characterization of the gut microbiota and the colonic immune response in acute severe ulcerative colitis : the multi-omics ITAC project
P173 Characterization of the gut microbiota and the colonic immune response in acute severe ulcerative colitis : the multi-omics ITAC project Open
Background Limited understanding exists regarding the pathogenesis of acute severe ulcerative colitis (UC). Microorganisms are proposed as potential triggers due to the resemblances to infectious colitis and the essential role played by gu…
View article: P805 The persistence of subcutaneous infliximab is equivalent to intravenous form in patients with inflammatory bowel diseases
P805 The persistence of subcutaneous infliximab is equivalent to intravenous form in patients with inflammatory bowel diseases Open
Background Switching from intravenous (IV) infliximab to subcutaneous (SC) is a new tool in treating patients with inflammatory bowel disease (IBD). This study aimed to evaluate the persistence and tolerance of SC IFX compared to IV IFX an…
View article: Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID
Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID Open
View article: Time trend in surgical indications and outcomes in ulcerative colitis—A two decades in-depth retrospective analysis
Time trend in surgical indications and outcomes in ulcerative colitis—A two decades in-depth retrospective analysis Open
View article: COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure
COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure Open
View article: Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn’s Disease: A Multicentre Case-Control Study
Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn’s Disease: A Multicentre Case-Control Study Open
Crohn’s disease (CD) is associated with an increased risk of small bowel neoplasia (SBN). We aimed to assess preoperative predictors of SBN in CD patients. We conducted a retrospective case-control study including CD patients who underwent…
View article: Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy
Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy Open
Immunomodulators, conventional immunosuppressants, and/or biologics are used more often, earlier, and longer than before in patients with inflammatory bowel disease (IBD). Along with this, the lifetime risk for cancer is estimated to be 33…
View article: P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study
P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study Open
Background Breast cancer is the most common malignancy observed in patients with inflammatory bowel diseases (IBD) unrelated to the disease or its treatment (Poullenot F et al. JCC 2022). The main aim of our study was to assess the risk of…
View article: Management of acute mesenteric ischaemia: Results of a worldwide survey
Management of acute mesenteric ischaemia: Results of a worldwide survey Open
View article: Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNFα failure: A retrospective multicenter study
Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNFα failure: A retrospective multicenter study Open
View article: High parenteral carbohydrate intakes in patients with chronic intestinal failure are associated with accumulation of advanced glycation end products.
High parenteral carbohydrate intakes in patients with chronic intestinal failure are associated with accumulation of advanced glycation end products. Open
Advanced glycation end-products (AGE) are the product of non-enzymatic reactions between reduced carbohydrates, peptides, lipids, nucleic acids. AGE accumulate over time, they are considered as the metabolic memory. In certain pathologies …
View article: Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID
Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID Open
View article: Management of Central Venous Catheters in Children and Adults on Home Parenteral Nutrition: A French Survey of Current Practice
Management of Central Venous Catheters in Children and Adults on Home Parenteral Nutrition: A French Survey of Current Practice Open
Although central venous catheter (CVC)-related thrombosis (CRT) is a severe complication of home parenteral nutrition (HPN), the amount and quality of data in the diagnosis and management of CRT remain low. We aimed to describe current pra…
View article: Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID
Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID Open
View article: Compliance with Gluten Free Diet Is Associated with Better Quality of Life in Celiac Disease
Compliance with Gluten Free Diet Is Associated with Better Quality of Life in Celiac Disease Open
The quality of life (QOL) of patients with celiac disease (CD) can be altered by both symptoms of the disease and by the restrictions of the gluten-free diet (GFD). The objective was to determine the factors associated with better QOL in a…
View article: P524 Compared efficacy of ustekinumab and anti-TNF agents as first-line biological therapy in luminal Crohn’s disease
P524 Compared efficacy of ustekinumab and anti-TNF agents as first-line biological therapy in luminal Crohn’s disease Open
Background Real-life data on the efficacy of ustekinumab as first-line therapy for the treatment of moderate to severe Crohn’s disease (CD) is lacking. The objective of this study was to compare the clinical remission rate at 3 months of p…
View article: A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease
A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease Open
Introduction: Patients treated with biologics for inflammatory bowel disease (IBD) have an increased risk of severe infections. Real-life vaccination coverage in this population remains low despite international vaccination guidelines. The…
View article: P472 Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysis
P472 Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysis Open
Background The management of ulcerative colitis (UC) has been improved due to progresses in medical and surgical practices during the past twenty years. Yet the impact of new therapies on the evolution of the three colectomy’s indications …
View article: P350 Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study
P350 Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study Open
Background Knowledge about the cancer risk when initiating a biologic in Inflammatory Bowel Disease (IBD) patients with prior malignancy remains scarce especially for vedolizumab. Our aim was to evaluate the rate of incident cancer in a co…
View article: Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey
Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey Open
View article: Erratum to: Predictors of Perianal Fistula Relapse in Crohn’s Disease
Erratum to: Predictors of Perianal Fistula Relapse in Crohn’s Disease Open
View article: The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease Open
Background and Aim The inflammatory bowel disease [IBD]-disk is a 10-item self-questionnaire that is used to assess IBD-related disability. The aim of the present study was to evaluate this tool in the assessment of IBD daily-life burden. …
View article: Endoscopic balloon dilation of colorectal strictures complicating Crohn’s disease: a multicenter study
Endoscopic balloon dilation of colorectal strictures complicating Crohn’s disease: a multicenter study Open